# Chestnut (Castanea crenata) Inner-Shell Extract Attenuates Barium-Chloride-Induced Injury and Denervation-Induced Atrophy in Skeletal Muscle of Mice

**Authors:** Jin-Hwa Kim, Eun-Hye Chung, Jeong-Won Kim, Ji-Soo Jeong, Chang-Yeop Kim, Su-Ha Lee, Je-Won Ko, Je-Oh Lim, Tae-Won Kim

PMC · DOI: 10.3390/nu17132116 · 2025-06-26

## TL;DR

Chestnut inner-shell extract helps reduce muscle injury and atrophy in mice by combating oxidative stress and inflammation.

## Contribution

The study demonstrates the therapeutic potential of chestnut inner-shell extract in skeletal muscle damage and atrophy for the first time.

## Key findings

- CIE restored muscle fiber structure and protein levels in BaCl2-induced injury models.
- CIE reduced apoptosis and modulated the Akt/mTOR pathway in denervation-induced atrophy.
- CIE suppressed oxidative stress regulators NRF2 and HO-1 in H2O2-treated myoblasts.

## Abstract

Background/Objectives: Chestnut inner shells, traditionally used in Korean and Chinese herbal medicine, contain antioxidant and anti-inflammatory compounds that contribute to complementary medicine. This study aimed to explore the therapeutic effects of chestnut inner-shell extract (CIE) on skeletal muscle injury and atrophy using both in vivo and in vitro models. Methods: We used three experimental models representing distinct pathological mechanisms: (1) barium chloride (BaCl2)-induced muscle injury to model acute myofiber damage, (2) sciatic nerve transection to model chronic neurogenic muscle atrophy, and (3) H2O2-treated C2C12 myoblasts to model oxidative-stress-related myogenic impairment. Histological analyses (e.g., hematoxylin and eosin staining and cross-sectional area measurement) and molecular analyses were performed to evaluate the effects of CIE on muscle structure, apoptosis, and oxidative stress. Results: In the BaCl2 injury model, CIE treatment significantly restored the muscle fiber structure, with muscle protein levels returning to near-normal levels. In the denervation-induced muscle atrophy model, CIE treatment led to a dose-dependent decrease in apoptosis-related factors (especially cleaved caspase-3) and mitigated the Akt/mTOR signaling pathway. In the in vitro oxidative stress model, CIE suppressed the expression of NRF2 and HO-1, which are key oxidative stress response regulators. Conclusions: These findings suggest that CIE may offer therapeutic potential for mitigating skeletal muscle damage, atrophy, and oxidative stress.

## Linked entities

- **Proteins:** AKT1 (AKT serine/threonine kinase 1), MTOR (mechanistic target of rapamycin kinase), GABPA (GA binding protein transcription factor subunit alpha), HMOX1 (heme oxygenase 1)
- **Chemicals:** BaCl2 (PubChem CID 25204), H2O2 (PubChem CID 784)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}
- **Diseases:** muscle atrophy (MESH:D009133), inflammatory (MESH:D007249), Atrophy (MESH:D001284), myogenic impairment (MESH:D060825), muscle injury (MESH:D009135), damage (MESH:D020263)
- **Chemicals:** eosin (MESH:D004801), hematoxylin (MESH:D006416), BaCl2 (MESH:C024986), H2O2 (MESH:D006861), CIE (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Castanea crenata (Japanese chestnut, species) [taxon 103480]
- **Cell lines:** C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12251227/full.md

---
Source: https://tomesphere.com/paper/PMC12251227